3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Recurrence
2
Lymphoma
2
Solid Tumors
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Cytokine Release Syndrome
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Advanced Liver Cancers
1
Interventions
Gemcitabine
19
130-nm albumin-bound paclitaxel
16
Specimen Handling
15
Irinotecan
11
Magnetic Resonance Spectroscopy
10
Fluorouracil
10
Leucovorin
9
Biopsy
9
Oxaliplatin
8
pembrolizumab
7
Cyclophosphamide
7
fludarabine
6
Cisplatin
5
Pemetrexed
4
Cetuximab
4
Albumin-Bound Paclitaxel
4
zimberelimab
3
trastuzumab deruxtecan
3
olaparib
3
irinotecan sucrosofate
3
durvalumab
3
dehydroftorafur
3
aldesleukin
3
Taxes
3
Radiosurgery
3
Nivolumab
3
Immunoglobulin G
3
Disulfides
3
Carboplatin
3
veliparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
tocilizumab
×
30 days
×
Clear all
No trials found.